Why prevent, diagnose and treat congenital toxoplasmosis?

Evidence that prevention, diagnosis and treatment of toxoplasmosis is beneficial developed as follows: anti-parasitic agents abrogate Toxoplasma gondiitachyzoite growth, preventing destruction of infected, cultured, mammalian cells and cure active infections in experimental animals, including primat...

Full description

Bibliographic Details
Main Authors: Rima McLeod, Francois Kieffer, Mari Sautter, Tiffany Hosten, Herve Pelloux
Format: Article
Language:English
Published: Fundação Oswaldo Cruz (FIOCRUZ) 2009-03-01
Series:Memorias do Instituto Oswaldo Cruz
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762009000200029
_version_ 1827833144508678144
author Rima McLeod
Francois Kieffer
Mari Sautter
Tiffany Hosten
Herve Pelloux
author_facet Rima McLeod
Francois Kieffer
Mari Sautter
Tiffany Hosten
Herve Pelloux
author_sort Rima McLeod
collection DOAJ
description Evidence that prevention, diagnosis and treatment of toxoplasmosis is beneficial developed as follows: anti-parasitic agents abrogate Toxoplasma gondiitachyzoite growth, preventing destruction of infected, cultured, mammalian cells and cure active infections in experimental animals, including primates. They treat active infections in persons who are immune-compromised, limit destruction of retina by replicating parasites and thereby treat ocular toxoplasmosis and treat active infection in the fetus and infant. Outcomes of untreated congenital toxoplasmosis include adverse ocular and neurologic sequelae described in different countries and decades. Better outcomes are associated with treatment of infected infants throughout their first year of life. Shorter intervals between diagnosis and treatment in utero improve outcomes. A French approach for diagnosis and treatment of congenital toxoplasmosis in the fetus and infant can prevent toxoplasmosis and limit adverse sequelae. In addition, new data demonstrate that this French approach results in favorable outcomes with some early gestation infections. A standardized approach to diagnosis and treatment during gestation has not yet been applied generally in the USA. Nonetheless, a small, similar experience confirms that this French approach is feasible, safe, and results in favorable outcomes in the National Collaborative Chicago-based Congenital Toxoplasmosis Study cohort. Prompt diagnosis, prevention and treatment reduce adverse sequelae of congenital toxoplasmosis.
first_indexed 2024-03-12T05:25:34Z
format Article
id doaj.art-375026510c014fa0b44dbc3cf0c99144
institution Directory Open Access Journal
issn 0074-0276
1678-8060
language English
last_indexed 2024-03-12T05:25:34Z
publishDate 2009-03-01
publisher Fundação Oswaldo Cruz (FIOCRUZ)
record_format Article
series Memorias do Instituto Oswaldo Cruz
spelling doaj.art-375026510c014fa0b44dbc3cf0c991442023-09-03T07:24:30ZengFundação Oswaldo Cruz (FIOCRUZ)Memorias do Instituto Oswaldo Cruz0074-02761678-80602009-03-01104232034410.1590/S0074-02762009000200029Why prevent, diagnose and treat congenital toxoplasmosis?Rima McLeodFrancois KiefferMari SautterTiffany HostenHerve PellouxEvidence that prevention, diagnosis and treatment of toxoplasmosis is beneficial developed as follows: anti-parasitic agents abrogate Toxoplasma gondiitachyzoite growth, preventing destruction of infected, cultured, mammalian cells and cure active infections in experimental animals, including primates. They treat active infections in persons who are immune-compromised, limit destruction of retina by replicating parasites and thereby treat ocular toxoplasmosis and treat active infection in the fetus and infant. Outcomes of untreated congenital toxoplasmosis include adverse ocular and neurologic sequelae described in different countries and decades. Better outcomes are associated with treatment of infected infants throughout their first year of life. Shorter intervals between diagnosis and treatment in utero improve outcomes. A French approach for diagnosis and treatment of congenital toxoplasmosis in the fetus and infant can prevent toxoplasmosis and limit adverse sequelae. In addition, new data demonstrate that this French approach results in favorable outcomes with some early gestation infections. A standardized approach to diagnosis and treatment during gestation has not yet been applied generally in the USA. Nonetheless, a small, similar experience confirms that this French approach is feasible, safe, and results in favorable outcomes in the National Collaborative Chicago-based Congenital Toxoplasmosis Study cohort. Prompt diagnosis, prevention and treatment reduce adverse sequelae of congenital toxoplasmosis.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762009000200029congenital toxoplasmosispreventiontreatment
spellingShingle Rima McLeod
Francois Kieffer
Mari Sautter
Tiffany Hosten
Herve Pelloux
Why prevent, diagnose and treat congenital toxoplasmosis?
Memorias do Instituto Oswaldo Cruz
congenital toxoplasmosis
prevention
treatment
title Why prevent, diagnose and treat congenital toxoplasmosis?
title_full Why prevent, diagnose and treat congenital toxoplasmosis?
title_fullStr Why prevent, diagnose and treat congenital toxoplasmosis?
title_full_unstemmed Why prevent, diagnose and treat congenital toxoplasmosis?
title_short Why prevent, diagnose and treat congenital toxoplasmosis?
title_sort why prevent diagnose and treat congenital toxoplasmosis
topic congenital toxoplasmosis
prevention
treatment
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762009000200029
work_keys_str_mv AT rimamcleod whypreventdiagnoseandtreatcongenitaltoxoplasmosis
AT francoiskieffer whypreventdiagnoseandtreatcongenitaltoxoplasmosis
AT marisautter whypreventdiagnoseandtreatcongenitaltoxoplasmosis
AT tiffanyhosten whypreventdiagnoseandtreatcongenitaltoxoplasmosis
AT hervepelloux whypreventdiagnoseandtreatcongenitaltoxoplasmosis